Disc Medicine (IRON) Change in Accured Expenses (2020 - 2026)

Disc Medicine's (IRON) quarterly Change in Accured Expenses came in at -$8.7 million in Q1 2026, down 136.76% year-on-year from $23.8 million in Q1 2025, and down 296.45% on a QoQ basis from $4.4 million in Q4 2025.

Disc Medicine (IRON) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Disc Medicine (IRON) has 7 years of Change in Accured Expenses data on file, last reported at -$8.7 million in Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 136.76% year-over-year to -$8.7 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a 69.46% increase from a year earlier, with the FY2025 full-year figure at $6.9 million, up 309.4% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$8.7 million, down from $4.4 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for IRON reached as high as $5.0 million in Q3 2025 and fell as low as -$8.7 million in Q1 2026.
  • Historically, Change in Accured Expenses has averaged $186470.6 across 5 years, with a median of $942000.0 in 2023.
  • Across the five-year window, Change in Accured Expenses jumped 3824.53% in 2022 and slumped 11477.78% in 2023, its largest moves.
  • Year by year, Change in Accured Expenses stood at $2.0 million in 2022, then soared by 36.17% to $2.7 million in 2023, then retreated by 13.39% to $2.3 million in 2024, then soared by 90.98% to $4.4 million in 2025, then sank by 296.45% to -$8.7 million in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were -$8.7 million in Q1 2026, $4.4 million in Q4 2025, and $5.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 66,320.50 Bn 66,320.21 Bn - 1.13 Mn
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - 931,000.00
4 BeOne Medicines 472.93 Bn 468.14 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 122.22 Bn 114.98 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 69.96 Bn 61.21 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.66 Bn 62.66 Bn - -
8 Argenx Se 56.07 Bn 50.89 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.60 Bn 34.59 Bn 959.66 Mn -176.03 Mn
10 Disc Medicine 2.88 Bn 2.88 Bn - -8.73 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.73 Mn
Mar 31, 2026 -8.73 Mn
Dec 31, 2025 4.45 Mn
Dec 31, 2025 4.45 Mn
Sep 30, 2025 4.95 Mn
Sep 30, 2025 4.95 Mn
Jun 30, 2025 1.17 Mn
Jun 30, 2025 1.17 Mn
Mar 31, 2025 -3.69 Mn
Mar 31, 2025 -3.69 Mn
Dec 31, 2024 2.33 Mn
Dec 31, 2024 2.33 Mn
Sep 30, 2024 1.48 Mn
Sep 30, 2024 1.48 Mn
Jun 30, 2024 962,000.00
Jun 30, 2024 962,000.00
Mar 31, 2024 -3.09 Mn
Mar 31, 2024 -3.09 Mn
Dec 31, 2023 2.69 Mn
Dec 31, 2023 2.69 Mn